HER2
Clinical trials for HER2 explained in plain language.
Never miss a new study
Get alerted when new HER2 trials appear
Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New two-drug attack on spreading colon cancer enters testing
Disease control Not yet recruitingThis study is testing if a new drug called SHR-1811, when combined with an existing drug (bevacizumab), can help control advanced colorectal cancer that has spread and worsened after standard first treatment. It will involve about 80 adults whose cancer has a certain level of a p…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New scan aims to see cancer more clearly during treatment
Knowledge-focused Not yet recruitingThis study is testing a new imaging tracer called [68Ga]Ga-ABY-025 to see if it can help doctors better identify and visualize tumors in patients receiving standard HER2-targeted cancer therapy. It will involve about 30 adults with advanced HER2-positive cancers who are undergoin…
Matched conditions: HER2
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC